Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
MDCLF
MDCLF News & Events
-
Add to Watchlist
Trade MDCLF
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
MDCLF News
FDA accepts Teva's application for Uzedy for bipolar I disorder
Feb 25 2025
SeekingAlpha
Medincell: Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals
Feb 10 2025
Yahoo Finance
Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals
Feb 10 2025
Yahoo Finance
Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement
Dec 09 2024
Yahoo Finance
3 Growth Companies On Euronext Paris With 19% Insider Ownership
Sep 09 2024
Yahoo Finance
Explore Three Growth Companies With High Insider Ownership On Euronext Paris
May 27 2024
Yahoo Finance
AbbVie to develop long-acting injectables in a deal worth up to $1.9B
Apr 16 2024
SeekingAlpha
MDCLF Events
No data
MDCLF Monitor News
No data
MDCLF Earnings Analysis
No Data
People Also Watch
